Literature DB >> 6855020

Falciform retinal fold as sign of familial exudative vitreoretinopathy.

M Nishimura, T Yamana, M Sugino, T Kohno, Y Yamana, M Minei, H Sanui.   

Abstract

We studied family members of 9 patients with falciform retinal fold, and found a number of cases showing features of familial exudative vitreoretinopathy (FEVR) in the fundi. Retinal fold was also seen in the eye of a cousin of the propositus. Three cases with falciform retinal fold were bilateral and 7 cases were unilateral. Retinal folds were located in the temporal half of the fundis in 11 of the 13 eyes with retinal fold. These 11 eyes showed avascularized zones of retinal vessels with scalloped edges in the periphery; in the 2 remaining eyes the retinal vessels were restricted within the fold. Thirty-one eyes of 18 cases, members of 7 pedigrees, showed features of FEVR. The observed avascularized zones with scalloped pattern of the vessels and vitreoretinal involvements were divided into 3 groups: 23 eyes of stage 1, 6 eyes of stage 2, and 2 eyes of stage 3, respectively. It was, therefore, concluded that falciform retinal fold being located temporally or bilaterally could be one of the signs of FEVR and that FEVR was a disease affecting regression of the hyaloid vascular system and development of the retinal vessels during fetal life. FEVR was classified into 4 groups: type 1, type 2, type 3 and type 4 of falciform retinal fold. The disease may be transmitted as autosomal dominant inheritance.

Entities:  

Mesh:

Year:  1983        PMID: 6855020

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  10 in total

1.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

Review 2.  Familial exudative vitreoretinopathy and related retinopathies.

Authors:  D F Gilmour
Journal:  Eye (Lond)       Date:  2014-10-17       Impact factor: 3.775

3.  CDK19 is disrupted in a female patient with bilateral congenital retinal folds, microcephaly and mild mental retardation.

Authors:  Arijit Mukhopadhyay; Jamie M Kramer; Gerard Merkx; Dorien Lugtenberg; Dominique F Smeets; Merel A W Oortveld; Ellen A W Blokland; Jyoti Agrawal; Annette Schenck; Hans van Bokhoven; Erik Huys; Eric F Schoenmakers; Ad Geurts van Kessel; C Erik van Nouhuys; Frans P M Cremers
Journal:  Hum Genet       Date:  2010-06-22       Impact factor: 4.132

4.  X linked exudative vitreoretinopathy: clinical features and genetic linkage analysis.

Authors:  P Fullwood; J Jones; S Bundey; J Dudgeon; A R Fielder; M W Kilpatrick
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

5.  Surgical treatments for fibrous tissue extending to the posterior retina in eyes with familial exudative vitreoretinopathy.

Authors:  Mari Takahashi; Tadashi Yokoi; Satoshi Katagiri; Tomoyo Yoshida-Uemura; Sachiko Nishina; Noriyuki Azuma
Journal:  Jpn J Ophthalmol       Date:  2017-11-03       Impact factor: 2.447

6.  Microcephaly, microphthalmos, and retinal folds: report of a family.

Authors:  I D Young; A R Fielder; K Simpson
Journal:  J Med Genet       Date:  1987-03       Impact factor: 6.318

7.  Unilateral Familial Exudative Vitreoretinopathy: Clinical Profile and Pathology.

Authors:  Nina S Boal; Alberto G Distefano; Stephen P Christiansen; Nora V Laver
Journal:  Case Rep Ophthalmol       Date:  2021-05-10

8.  Analysis of Predisposing Clinical Features for Worsening Traction After Treatment of Familial Exudative Vitreoretinopathy in Children.

Authors:  G Baker Hubbard; Alexa L Li
Journal:  Am J Ophthalmol       Date:  2020-07-21       Impact factor: 5.258

9.  Fzd4 Haploinsufficiency Delays Retinal Revascularization in the Mouse Model of Oxygen Induced Retinopathy.

Authors:  Michael H Ngo; Joanna Borowska-Fielding; Godfrey Heathcote; Sara Nejat; Melanie E Kelly; Christopher R McMaster; Johane M Robitaille
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

10.  Electroretinographic effects of retinal dragging and retinal folds in eyes with familial exudative vitreoretinopathy.

Authors:  Yukari Yaguchi; Satoshi Katagiri; Yoko Fukushima; Tadashi Yokoi; Sachiko Nishina; Mineo Kondo; Noriyuki Azuma
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.